click below
click below
Normal Size Small Size show me how
WEEK 19:
Haemostasis and Coagulation
| Question | Answer |
|---|---|
| types of clotting mechanisms | intrinsic and extrinsic |
| intrinsic clotting mechanism | activated by trauma in vessel wall |
| extrinsic clotting mechanism | damaged tissue releases thromboplastin |
| amplification cascade | |
| platelets | ] |
| adhesion slide 9** | |
| aggregation | |
| lab tests (3) | |
| bleeding time | incisions to forearm with venous cuff due to thombrocytopenia |
| prothrombin time (international normalised ratio INR) | time for coagulation following addition of thromboplastin |
| activated partial thromboplastin time (APTT) | examines the intrinsic pathway |
| clotting and bleeding disorders (3) | thrombosis, venous, and AF |
| thrombosis clot | unwanted blot clots |
| venous | cloths form in veins (DVT) due to stasis of blood and can travel to lungs) PE |
| AF | risk fo TIA |
| activated partial thromboplastin time (APTT) altered by (8) | changes in factors XII, XI, IX, VIII, X, V, II or I |
| prothrombin time (international normalised ratio INR) is prolonged by | abnormalities of factors VII, X, V, II, or I, liver disease of warfarin |
| arterial thrombosis (15) | |
| difference between venous and arterial thrombosis | venous is more of a coagulation factor event (DVT) but arterial is more of a platelet event (MIs and TIA) |
| haemophilia types | A and B |
| haemophilia A | |
| haemophilia B | deficiemcy of factor IX treated by prophylactic factor X |
| haemophilia B treatment | |
| haemophilia B A | prohylactic factor IX |
| haemophilia B treatment | |
| Von Willebrand's disease | hereditary lack/ defect in WF leading to increased bruising, nose bleeds, and analogue of vasopression ADh nd wWF) and money) gonna joint me lall |
| liver disease | reduced synthesis of blotting blood lead to increased bleeding positionn if not increased for bronthombin time |
| thrombocytopoeina | reduced platllet umber |
| thrombocytlopenia symptoms | idiopathic, viral, drug induced and toxins and skin on motuh |
| disseminated intravascular coagulation | large amount of firbin in pocoagulant material eg aminiotic fluid |
| factor V kLeiden mutation mararhoron =** |